DFX Intelligence

Data Factory

Immunai

We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:19ab08c6-7a21-43ba-936a-76e82ce99dac

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 2:09 AM UTC and rebuilt at most every 15 minutes.

Relationships: 3
Dated events: 1
On other graphs: 1
Observed: Sep 12, 2026 to Sep 17, 2026
7 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Immunai

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 3
People: 0
Website: immunai.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
Catalio Capital Management, LP	Multi stage VC	n/a	n/a	unknown	Unknown
TLV Partners	Institutional VC	n/a	n/a	unknown	Unknown
TLV Partners Management Ltd	Multi stage VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (3)

← Catalio Capital Management, LPFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← TLV Partners Management LtdFirmPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
← TLV PartnersFirmPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site

Dated events

1 bookkeeping events (roster, classification and holdings changes) folded below

Show 1 bookkeeping events

First seen by DFX
Sep 16, 2026
date not stated
Immunai no longer listed on TLV Partners's portfolio page

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:19ab08c6-7a21-43ba-936a-76e82ce99dac
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 2 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Immunai

We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:19ab08c6-7a21-43ba-936a-76e82ce99dac

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 2:09 AM UTC and rebuilt at most every 15 minutes.

Investor

Class

Fund

Partner

Role

Attribution

Catalio Capital Management, LP

Multi stage VC

n/a

unknown

Unknown

TLV Partners

Institutional VC

n/a

unknown

Unknown

TLV Partners Management Ltd

Multi stage VC

n/a

unknown

Unknown